MX369549B - Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento. - Google Patents

Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento.

Info

Publication number
MX369549B
MX369549B MX2014012799A MX2014012799A MX369549B MX 369549 B MX369549 B MX 369549B MX 2014012799 A MX2014012799 A MX 2014012799A MX 2014012799 A MX2014012799 A MX 2014012799A MX 369549 B MX369549 B MX 369549B
Authority
MX
Mexico
Prior art keywords
coating
production
tablets
formulations
hardness
Prior art date
Application number
MX2014012799A
Other languages
English (en)
Other versions
MX2014012799A (es
Inventor
Ognibene Roberto
Erika Bernhardt Sandra
Mechthild Breidung Melanie
Lubda Dieter
Ohrem Hans-Leonhard
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48045412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX369549(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2014012799A publication Critical patent/MX2014012799A/es
Publication of MX369549B publication Critical patent/MX369549B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención proporciona una formulación farmacéutica que se desintegra rápidamente en la forma de una tableta recubierta que tiene una resistencia mecánica o dureza incrementada. La invención se refiere adicionalmente a un proceso para la producción de la tableta recubierta y el uso de esas formulaciones.
MX2014012799A 2012-04-27 2013-04-02 Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento. MX369549B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12002988 2012-04-27
EP12006370 2012-09-11
PCT/EP2013/000971 WO2013159861A1 (de) 2012-04-27 2013-04-02 Tabletten mit überzug und deren herstellung

Publications (2)

Publication Number Publication Date
MX2014012799A MX2014012799A (es) 2015-01-22
MX369549B true MX369549B (es) 2019-11-12

Family

ID=48045412

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014012799A MX369549B (es) 2012-04-27 2013-04-02 Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento.

Country Status (13)

Country Link
US (1) US20150104512A1 (es)
EP (1) EP2844234B1 (es)
JP (2) JP6363993B2 (es)
KR (1) KR102092002B1 (es)
CN (1) CN104244931A (es)
BR (1) BR112014026439B1 (es)
CA (1) CA2871703C (es)
CL (1) CL2014002896A1 (es)
ES (1) ES2784134T3 (es)
IL (1) IL234998B (es)
MX (1) MX369549B (es)
TW (2) TWI697341B (es)
WO (1) WO2013159861A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
BR112018007634A2 (pt) * 2015-10-16 2018-11-06 Dee Kennie tablete oral revestido estável
JP6738477B2 (ja) * 2016-03-16 2020-08-12 ゴールデン オメガ ノルウェー アーエス ω−３脂肪酸誘導体を含む粉末及び錠剤、ならびにその製造方法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JP2018184375A (ja) * 2017-04-27 2018-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ダビガトランエテキシラート又は医薬的に許容されるその塩を含む錠剤及びその製造方法
JP7202898B2 (ja) * 2018-01-11 2023-01-12 沢井製薬株式会社 フィルムコーティングされた口腔内崩壊錠
CN118340736A (zh) * 2024-04-23 2024-07-16 海南恒诚三叶制药有限公司 头孢泊肟酯片及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2285520C2 (ru) * 2002-02-07 2006-10-20 Фармация Корпорейшн Фармацевтическая дозированная форма для доставки через слизистую оболочку
JP2008507587A (ja) * 2004-07-26 2008-03-13 テバ ファーマシューティカル インダストリーズ リミティド 腸溶性被覆されたコアー錠剤を有する投与形
AU2005266882A1 (en) * 2004-07-26 2006-02-02 Teva Pharmaceutical Indudstries, Ltd. Dosage forms with an enterically coated core tablet
EP2001450B1 (en) * 2006-03-31 2019-01-30 Rubicon Research Private Limited Directly compressible composite for orally disintegrating tablets
JP5243434B2 (ja) 2006-09-15 2013-07-24 ファイザー・プロダクツ・インク 急速に崩壊する錠剤
US20100004279A1 (en) * 2006-12-07 2010-01-07 Tomoyuki Watanabe Solid medicinal preparation containing mannitol or lactose
TW200924768A (en) * 2007-10-12 2009-06-16 Astrazeneca Ab Composition
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
KR101647855B1 (ko) 2008-06-20 2016-08-11 메르크 파텐트 게엠베하 직접 사출성형가능한 신속 붕해 정제 매트릭스
EP2395968B1 (en) * 2009-02-13 2024-01-17 Boehringer Ingelheim International GmbH Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
TWI455733B (zh) * 2009-03-30 2014-10-11 Toray Industries 口腔內崩壞性被覆錠劑
ES2739888T3 (es) 2009-11-30 2020-02-04 Adare Pharmaceuticals Inc Composiciones y comprimidos farmacéuticos con recubrimiento compresible y métodos de fabricación
CA2865380C (en) * 2012-02-22 2019-10-29 Toyama Chemical Co., Ltd. Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof

Also Published As

Publication number Publication date
JP6363993B2 (ja) 2018-07-25
EP2844234A1 (de) 2015-03-11
BR112014026439A2 (pt) 2017-06-27
KR102092002B1 (ko) 2020-03-23
TWI697341B (zh) 2020-07-01
ES2784134T3 (es) 2020-09-22
IL234998A0 (en) 2014-12-31
TW201811316A (zh) 2018-04-01
EP2844234B1 (de) 2020-01-08
CA2871703C (en) 2021-03-30
KR20150003891A (ko) 2015-01-09
JP2015514786A (ja) 2015-05-21
BR112014026439B1 (pt) 2022-05-31
JP2017193585A (ja) 2017-10-26
TW201410268A (zh) 2014-03-16
IL234998B (en) 2019-07-31
CL2014002896A1 (es) 2014-12-19
CA2871703A1 (en) 2013-10-31
MX2014012799A (es) 2015-01-22
CN104244931A (zh) 2014-12-24
WO2013159861A1 (de) 2013-10-31
US20150104512A1 (en) 2015-04-16

Similar Documents

Publication Publication Date Title
IL269054A (en) A pharmaceutical preparation containing tesimaltone for use in the treatment of 24-NON
MX369549B (es) Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento.
IL222268A (en) Preserved pyrollo-pyridines, containing pharmaceutical preparations, combined preparations containing them and their use in the preparation of medicines
CA141113S (en) Dispenser for pharmaceutical powder formulations
PH12019501970A1 (en) Pharmaceutical compositions for combination therapy
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
MX364229B (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
AU346046S (en) Shower faceplate
GB201106750D0 (en) Novel compounds
AU338203S (en) Pill case
MX2014008774A (es) Sistemas de perfume.
PH12019501301A1 (en) Pharmaceutical compositions for combination therapy
AU345217S (en) Fire detector
CA143485S (en) Display box
GB2497453B (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
IN2014DN09940A (es)
MX2016006087A (es) Formulaciones de desintegracion rapida y metodos de uso.
MX2013001793A (es) Producto para la esfera gastrica superior.
IN2015DN02358A (es)
WO2011107866A3 (en) Silyl-derivatives of polysaccharides
MX2012002631A (es) Capsulas con aroma.
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
WO2014027979A3 (en) Tablet formulations comprising tadalafil and dapoxetine

Legal Events

Date Code Title Description
FG Grant or registration